ETFIQData as of Nov 18, 2026. · etfiq.com/funds/mdyDownload PDF

MDY Fact Sheet: SPDR S&P MidCap 400 ETF Trust

Share
$626.03
close, Nov 20, 2026

Over the year to Nov 18, 2026, MDY returned +14.9% in total and charged 0.23% a year.

1-year total return
+11.3%
IJH +11.6% to Nov 20, 2026
Expense ratio
0.23%
a year
Net assets
$23.9bn
on Nov 20, 2026
Net flow, last 5 trading days
−$65.9m
daily basis to Nov 19, 2026

Growth of $10,000, 1 year

MDY $11,494 +14.9% · IJH $11,528 +15.3% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month−6.5%
3 months−10.3%
Year to date+4.5%
1 year+11.3%
3 years+39.9%
5 years+27.1%

Total return, distributions reinvested, each window to Nov 20, 2026.

Ten largest positions

HoldingWeight
U.S. Dollar0.83%
TechnipFMC plc0.73%
United Therapeutics Corporation0.73%
ATI Inc0.72%
US Foods Holding Corp.0.71%
Tenet Healthcare Corporation0.65%
XPO Inc.0.65%
Reliance Inc.0.65%
Entegris Inc.0.65%
Roivant Sciences Ltd.0.64%

MDY top ten by weight, 7.0% of the fund, of its 398 equity positions, from the holdings published by its issuer for Nov 19, 2026.

Facts

Equity fund · Tracks the S&P MidCap 400 Index · First traded May 4, 1995 · Benchmark S&P MidCap 400 Index, measured by IJH, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, MDY Fact Sheet: SPDR S&P MidCap 400 ETF Trust. Data as of Nov 18, 2026. https://etfiq.com/funds/mdy/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/mdy.